Scientists have developed a new tissue ‘scaffold’ technology that could one day enable the engineering of large organs
Research led by the Universities of Bristol and Liverpool has shown that it is possible to combine cells with a special scaffold to produce living tissue in the laboratory. It is hoped this can then be implanted into patients as a way of replacing diseased parts of the body.
Until now, the approach has generally been limited to growing small pieces of tissue, as larger dimensions reduce the oxygen supply to the cells in the centre.
A team of researchers, led by Dr Adam Perriman from the University of Bristol and Professor Anthony Hollander from the University of Liverpool, used cartilage tissue engineering as a model system for testing a new method of overcoming the oxygen limitation problem.
They synthesised a new class of artificial membrane binding proteins that can be attached to stems cells. By attaching an oxygen-carrying protein, myoglobin, to the stem cells before they are used to engineer cartilage, they ensure that each cell has its own oxygen reservoir that it can access when the oxygen in the scaffold drops to dangerously low levels.
Dr Perriman from Bristol’s School of Cellular and Molecular Medicine said: “From our preliminary experiments, we found that we could produce these artificial membrane binding proteins and paint the cells without affecting their biological function.
“However, we were surprised and delighted to discover that we could deliver the necessary quantity to the cells to supplement their oxygen requirements. It’s like supplying each cell with its own scuba tank, which it can use to breathe from when there is not enough oxygen in the local environment.”
The team’s findings, published today [17 June] in Nature Communications, could really expand the possibilities in tissue engineering, not only in cartilage, but also for other tissue such as cardiac muscle or bone.
Professor Hollander said: “We have already shown that stem cells can help create parts of the body that can be successfully transplanted into patients, but we have now found a way of making their success even better.
“Growing large organs remains a huge challenge but with this technology we have overcome one of the major hurdles.
“Creating larger pieces of cartilage gives us a possible way of repairing some of the worst damage to human joint tissue, such as the debilitating changes seen in hip or knee osteoarthritis or the severe injuries caused by major trauma, for example in road traffic accidents or war injuries.”
Their new methodology, describing the conversion of a normal protein into a membrane binding protein, is likely to pave the way for the development of a wide range of new biotechnologies.
Read more: Tissue ‘scaffold’ technology could help rebuild large organs
The Latest on: Tissue scaffold technology
[google_news title=”” keyword=”Tissue scaffold technology” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Tissue scaffold technology
- Engineered living materials: Scientists 3D print with bio-ink made from tobacco cellson May 1, 2024 at 5:21 am
Using a 3D printer and a bioink, scientists create an "engineered plant living material" (EPLM) that harnesses the power of cells.
- Abbott wins FDA approval for Esprit resorbable scaffoldon April 30, 2024 at 9:01 am
While RBC analysts wrote there’s “strong appetite” for the system, BTIG said the need to train centers could result in a “gradual” launch.
- Global Scaffold Technology Market is set to expand at a CAGR of 11.3% until 2034 | Future Market Insights, Inc.on April 30, 2024 at 3:45 am
The scaffold technology industry is expected to be valued at US$ 1,490.7 million by 2024. The market valuation is estimated to be US$ 4,348.6 million by 2034, projected at a CAGR of 11.3%.
- Biocompatible Polymers Market Poised for Explosive Growth: Reaching US$ 1.8 Billion by 2033on April 30, 2024 at 1:27 am
In 2023, the biocompatible polymers market is expected to be worth US$ 957 million. The market is expected to reach US$ 1,847.7 million by 2033, expanding at a 6.8% CAGR throughout the forecast period ...
- How to get a tight new jawline — without a facelifton April 29, 2024 at 4:01 pm
I came to an important realisation at a glamorous Greek wedding in the Alps earlier this year — I do not have the jawline of a rich woman. And I’m not talking the bride’s contemporaries here, I’m ...
- FDA Approves Bioresorbable Scaffold for BTK Lesionson April 29, 2024 at 1:30 pm
The approval marks the return of the dissolving-scaffold concept, which so far has failed to find success in the coronaries.
- Abbott wins FDA approval for dissolving drug-eluting scaffoldon April 29, 2024 at 10:17 am
The Espirit scaffold treats chronic limb-threatening ischemia (CLTI) below the knee (BTK). Abbott designed it to keep arteries open and deliver everolimus to support vessel healing prior to completely ...
- 3D Cell Culture Marketon April 28, 2024 at 10:16 pm
D Cell Culture Market an astounding US$ 3 billion by 2033, This trajectory represents a robust Compound Annual Growth Rate (CAGR) of 9%.
- Freeze casting—a guide to creating hierarchically structured materialson April 25, 2024 at 9:20 am
Freeze casting is an elegant, cost-effective manufacturing technique to produce highly porous materials with custom-designed hierarchical architectures, well-defined pore orientation, and ...
- 3D Cell Culture Market is expected to reach revenue of USD 5.0 Bn by 2032, at 12.0% CAGR: Insights by Dimension Market Researchon April 23, 2024 at 8:25 am
Exploring the Dynamics of the 3D Cell Culture Market by an In-Depth Analysis of Growth Trajectories, Key Players, and Future TrendsNew Jersey, New York, Los Angeles, Austin, San Diego, Philadelphia, ...
via Bing News